These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18200843)

  • 21. [Research progress of pharmaceutical and personal care products on ecological and human health].
    Liu Y; Zhu L; Li J
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):237-40. PubMed ID: 19408672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research.
    Caldwell DJ; Mastrocco F; Margiotta-Casaluci L; Brooks BW
    Chemosphere; 2014 Nov; 115():4-12. PubMed ID: 24636702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment on "life cycle comparison of environmental emissions from three disposal options for unused pharmaceuticals".
    Daughton CG
    Environ Sci Technol; 2012 Aug; 46(15):8519-20; discussion 8521-2. PubMed ID: 22734665
    [No Abstract]   [Full Text] [Related]  

  • 25. Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.
    Mansour F; Al-Hindi M; Saad W; Salam D
    Sci Total Environ; 2016 Jul; 557-558():31-43. PubMed ID: 26994791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
    Laenge R; Steger-Hartmann T; Schweinfurth H
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the environmental risk assessment of pharmaceuticals: Facts and fantasies.
    Tarazona JV; Escher BI; Giltrow E; Sumpter J; Knacker T
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():603-13. PubMed ID: 19886731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge.
    Cardoso O; Porcher JM; Sanchez W
    Chemosphere; 2014 Nov; 115():20-30. PubMed ID: 24602347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosensors for the Detection of Environmental and Urban Pollutions.
    Hashemi Goradel N; Mirzaei H; Sahebkar A; Poursadeghiyan M; Masoudifar A; Malekshahi ZV; Negahdari B
    J Cell Biochem; 2018 Jan; 119(1):207-212. PubMed ID: 28383805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals.
    Howard PH; Muir DC
    Environ Sci Technol; 2011 Aug; 45(16):6938-46. PubMed ID: 21740030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Matthew Effect and widely prescribed pharmaceuticals lacking environmental monitoring: case study of an exposure-assessment vulnerability.
    Daughton CG
    Sci Total Environ; 2014 Jan; 466-467():315-25. PubMed ID: 23911922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greener pharmaceuticals.
    Clark JH; Breeden SW; Summerton L
    Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
    [No Abstract]   [Full Text] [Related]  

  • 33. Genes help predict drugs' environmental impacts.
    Lubick N
    Environ Sci Technol; 2008 Aug; 42(15):5382-3. PubMed ID: 18754449
    [No Abstract]   [Full Text] [Related]  

  • 34. Environmental mass spectrometry: emerging contaminants and current issues.
    Richardson SD
    Anal Chem; 2002 Jun; 74(12):2719-41. PubMed ID: 12090660
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of Multiresidues Analytical Methods for the Quantitation of Pharmaceuticals in Environmental Solid Matrixes: Comparison of Analytical Development Strategy for Sewage Sludge, Manure, Soil, and Sediment Samples.
    Larivière A; Lissalde S; Soubrand M; Casellas-Français M
    Anal Chem; 2017 Jan; 89(1):453-465. PubMed ID: 28105844
    [No Abstract]   [Full Text] [Related]  

  • 36. Ecopharmacovigilance: Current state, challenges, and opportunities in China.
    Wang J; Hu X
    Indian J Pharmacol; 2014; 46(1):13-7. PubMed ID: 24550578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry.
    Grabic R; Fick J; Lindberg RH; Fedorova G; Tysklind M
    Talanta; 2012 Oct; 100():183-95. PubMed ID: 23141327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.
    Arnold KE; Brown AR; Ankley GT; Sumpter JP
    Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
    Santos LH; Araújo AN; Fachini A; Pena A; Delerue-Matos C; Montenegro MC
    J Hazard Mater; 2010 Mar; 175(1-3):45-95. PubMed ID: 19954887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PBT assessment and prioritization of contaminants of emerging concern: Pharmaceuticals.
    Sangion A; Gramatica P
    Environ Res; 2016 May; 147():297-306. PubMed ID: 26921826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.